相关实验视频

Updated: Jan 16, 2026

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

在AML的免疫疗法景观:定义知识差距,以合理的组合策略

Marion Subklewe¹, Sergio Rutella², Antonio Curti³

¹Department of Medicine III, University Hospital LMU Munich, Munich, Germany; Laboratory for Translational Cancer Immunology, Gene Center LMU, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and LMU University Hospital, Munich, Germany.

Seminars in hematology

|October 4, 2025

概括

免疫疗法对急性髓性白血病 (AML) 是有前途的,但目标特异性和免疫抑制等挑战仍然存在. 未来的战略重点是结合方法,将骨髓微环境整合到个性化治疗中.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

免疫疗法,包括针对CD19的CAR T细胞,已经改变了淋巴细胞恶性瘤.
由于生物复杂性和缺乏特定目标,急性髓性白血病 (AML) 在免疫疗法突破方面滞后.
目前的AML免疫疗法面临着诸如针对性/非针对性白血病毒性和免疫抑制等挑战.

研究的目的:

审查目前针对AML的免疫疗法平台.
探索包括免疫抵抗和骨髓微环境在内的挑战.
提出针对AML个性化组合免疫疗法的框架.

主要方法:

审查目前的免疫疗法平台 (基于抗体,T细胞重定向).
综合最近的临床数据和机械学的见解.
对免疫抵抗和骨髓微环境因素的分析.

主要成果:

与B细胞恶性瘤相比,AML免疫治疗面临着独特的障碍.
缺乏白血病特异性抗原和免疫抑制限制了疗效.
早期试验凸显了需要新策略的必要性.

结论:

免疫疗法具有AML的潜力,但需要克服重要的生物障碍.
了解骨髓微环境对于有效治疗至关重要.
个性化组合免疫疗法为AML治疗提供了一个有前途的未来方向.

关键词:

这些ADC是ADCs.在AML,AML就是AML.汽车车上的车辆.免疫治疗是一种免疫疗法.参与T细胞的参与者

更多相关视频

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...